Last updated on September 2018

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)

Brief description of study

To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of the negative symptoms of schizophrenia

Clinical Study Identifier: NCT02970305

Contact Investigators or Research Sites near you

Start Over

Ken Smith

Hoffman Estates, IL United States
  Connect »